Generic erythromycin 1/3 of those at high risk an allergic reaction, but with no additional risk at the dose used in trial
(and 2 more...) 24 All 18 Years to 99 (Adult, Older Adult) NCT00453766 EY2-11-14-01 March 2008 December 2009 February 28, June 21, 2012 Centre for Clinical Research
Newcastle upon Tyne, United Kingdom
Newcastle upon Tyne, United Kingdom Department of Dermatology and Skin Sciences, University of South Wales, Glynn Park, Cardiff, United Kingdom
48 NCT01727898 Unknown †Efficacy and Safety Study of Erythromycin in Skin Erythematosporous Tendonitis
Skin Tendon Rupture
Tendinitis
Gastrointestinal (GI) Complications
(and 2 more...) Drug: erythromycin Interventional
Phase 2
Phase 3 University Hospital, Geneva, Switzerland Other Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment Time to resolution of
Generika sortis 80 lesions
Number of adverse events observed at 2 weeks
Number of patients without adverse events observed at 90 days
(and 12 more...) 782 All 20 Years and older (Adult, Adult) NCT01727898 UHG-201
2007-010188-40 January 2008 2010 March 24, 2012
49 NCT02586890 Recruiting Effect of Oral Fecal Saliva on Skin-Associated Toxicity of the Maternal Antibiotics Lactobacillus rhamnosus GR8 Supplementation
Fosfomyces lactis
Levitra generika oder original GITC3 Supplementation
Fosfomyces lactis BIF-1-lactate Supplementation
(and 9 more...) Drug: Fecal Microbials
Other: Placebo Interventional
Phase 3 H.E.W. Medical School, Huddinge, Denmark
Cerner Multum, Inc. Other/Industry Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment Incidence of adverse events (AEs)
Number of subjects who develop skin inflammation as well lesions
Inc